Elite Stack 2 spans androgen receptor and metabolic pathway research, combining two characterized SARMs with a PPARδ agonist. This bundled research option provides all three compounds as high-purity liquid solutions for structured laboratory use.
GW-501516 (Cardarine) — 10mg/mL 30mL PPARδ agonist. Documented effects on fatty acid oxidation and mitochondrial biogenesis in preclinical models. Extensively referenced in endurance capacity and metabolic substrate utilization research.
MK-2866 (Ostarine) — 25mg/mL 30mL Non-steroidal AR partial agonist. The most extensively studied SARM in published clinical research, with Phase II trial data available. Frequently referenced in lean mass, bone density, and AR tissue selectivity studies.
LGD-4033 (Ligandrol) — 10mg/mL 30mL Non-steroidal AR full agonist with the highest binding affinity among characterized SARMs in published literature. Phase I clinical pharmacokinetic data available. Used in AR selectivity, anabolic pathway, and HPG axis modulation research.
Research Applications AR versus PPARδ pathway comparison, metabolic and anabolic signaling interaction studies, partial versus full agonist analysis, multi-compound stability research.
Specifications Form: Lab-grade liquid solution · Volume: 30mL each · COA: Third-party verified · Storage: Cool, dry, away from light · Ships same day from Texas
For laboratory and preclinical research use only. Not for human or veterinary consumption.
Reviews
There are no reviews yet